The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

ABSTRACT:
OriginalsprogEngelsk
TidsskriftB M C Endocrine Disorders
Vol/bind10
Sider (fra-til)3
ISSN1472-6823
DOI
StatusUdgivet - 1 jan. 2010

ID: 34115853